Crossroads Strategies, LLC
Crossroads Strategies, LLC filed a Q2 report for Broad Institute on July 17, 2026, reporting $50,000 in lobbying income.
Lobbying for Broad Institute · nonprofit independent biomedical research institute
General education about biomedical research and support for scientific funding. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments.
General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. Support for the NIH All of Us Program. FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance.FY2027 National Defense Authorization Act (H.R.8800/S.4784) and FY2027 Department of Defense Appropriations Act (H.R.9495).
General education about biomedical research and support for scientific funding. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. Education and awareness regarding genetic medicines for rare and ultra-rare diseases.
Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance.FY2027 National Defense Authorization Act (H.R.8800/S.4784) and FY2027 Department of Defense Appropriations Act (H.R.9495). Education and discussion regarding Broad Institute capabilities and technologies relevant to national biological intelligence, biosurveillance, and reconnaissance (ISR).